Possibly as late as 2024 or later.
China’s industrial policies may boost its number of small-scale chemical intermediate producers, increasing the risk that certain opportunistic firms may venture into supplying various precursors for…
www.cfr.org
“As of December 2023, Chinese authorities
granted forty fentanyl production licenses to five domestic pharmaceutical companies (Table 3). These companies have been given special permission to produce fentanyl APIs, injections, and transdermal patches for medical use. There are not yet any clinically authorized oral dosage formulations in China. The use of fentanyl injections is strictly restricted to hospitals and requires special prescriptions from doctors.”